COVID-19 prophylaxis with immunoglobulin Y (IgY) for the world population: The critical role that governments and non-governmental organizations can play.

Autor:	Frumkin LR; SPARK at Stanford, Stanford University, School of Medicine, Stanford, California, USA., Lucas M; Medical School, The University of Western Australia, Perth, Western Australia, Australia., Wallach M; University of Technology Sydney, Sydney, New South Wales, Australia.; SPARK Sydney, Sydney, New South Wales, Australia., Scribner CL; Independent Regulatory Consultant, Oakland, California, USA., St John T; SPARK at Stanford, Stanford University, School of Medicine, Stanford, California, USA., Mochly-Rosen D; SPARK at Stanford, Stanford University, School of Medicine, Stanford, California, USA.; Department of Chemical and Systems Biology, Stanford University, School of Medicine, Stanford, California, USA.; SPARK Global, Stanford University, School of Medicine, Stanford, California, USA.
Jazyk:	angličtina
Zdroj:	Journal of global health [J Glob Health] 2022 Dec 03; Vol. 12, pp. 03080. Date of Electronic Publication: 2022 Dec 03.
DOI:	10.7189/jogh.12.03080
Abstrakt:	Competing Interests: Disclosure of interest: The authors completed the ICMJE Disclosure of Interest Form (available upon request from the corresponding author) and declare the following activities and relationships: DM-R is named on a patent filed for composition and methods for passive immunization against viral infections such as SARS-CoV-2. MW is a consultant for Camus, Inc, Minnesota. The remaining authors declare no relevant interests.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu